European Commission President Ursula von der Leyen said Wednesday that the EU administrative arm would spend $117 million on immediate COVID-19 testing as a virus across Europe.
In statements to journalists in Brussels, Von der Leyen said that, unlike last spring, when the pandemic began, each and every European country felt the effects of a momentary wave of the virus. spread across the continent.
The firm reports that nearly 6. 5 million more people have the virus in EU member countries, as well as Britain, Iceland, Liechtenstein, Norway and Switzerland.
Von der Leyen says they are purchasing immediate antigen verification as another tool to help control COVID-19. Finger puncture antigen checking is not considered as reliable as the popular “PCR check” with nasal swab, but it works much faster, with effects that can be obtained at the checkpoint in 15 minutes.
European fitness experts say the virus is evolving too fast to rely on tests that can take days. Von der Leyen also suggested that data on the virus be helped to share data, saying it will help identify where greater capacity of the extensive care unit can be discovered and better organize cross-border patient care.
Von der Leyen also called on Member States to start preparing national vaccination plans and to review them now at EU level. He said everyone should be ready for the arrival of the first vaccine, which, at best, could start arriving in April with monthly deliveries of 20 to 50 million doses.